Drug Shortage Report for AURO-CITALOPRAM
| Report ID | 128084 |
| Drug Identification Number | 02275562 |
| Brand name | AURO-CITALOPRAM |
| Common or Proper name | Citalopram |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CITALOPRAM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30's, 100's and 500's |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2020-11-06 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2020-12-21 |
| Shortage status | Resolved |
| Updated date | 2020-12-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-11-06 | English | Compare |